Zenas Biopharma, Inc

Zenas Biopharma, Inc., located in Waltham, MA, is a dedicated team focused on developing therapies for autoimmune diseases, aiming to address significant unmet patient needs and transform lives. Their investigational drug, Obexelimab, is a bi-functional monoclonal antibody designed to suppress B cell activity, which plays a key role in many autoimmune conditions.

The company is committed to understanding patient experiences and introducing transformative therapies that help individuals realize the lives they intended. With a strong emphasis on leadership in the development and commercialization of these therapies, Zenas Biopharma strives to advance its programs across multiple autoimmune diseases.

Generated from the website